Home › Plexiform Neurofibroma › Indiana
Plexiform Neurofibroma clinical trials in Indiana
3 studies for Plexiform Neurofibroma are looking for participants at sites in Indiana.
Cities in Indiana
Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas
- Riley Hospital for Children/Indiana University, Indianapolis
RecruitingPhase 1
Ages 16 and older · All sexes · Updated Oct 2, 2026 · NCT06502171A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
- Indiana University, Indianapolis
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Jul 29, 2026 · NCT06541847Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
- Riley Hospital for Children/Indiana University, Indianapolis
RecruitingPhase 2
Ages 1 to 8 · All sexes · Updated May 29, 2026 · NCT06188741From ClinicalTrials.gov, data retrieved Oct 3, 2026. Each study sets its own eligibility; the study team decides who can join.